Ballaho, Noridzna Shanaia M.
HRN: 25-18-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/25/2024
10/31/2024
IVT
100mg
Q8
E.Histolytica
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes